| Product Code: ETC7652290 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of gammaretroviral vectors to Israel in 2024 were primarily sourced from top exporting countries including Switzerland, USA, Germany, China, and Belgium. Despite a negative compound annual growth rate (CAGR) from 2020 to 2024, there was a notable growth rate of 8.63% from 2023 to 2024. The high Herfindahl-Hirschman Index (HHI) indicates a concentration of imports among these key countries, suggesting a stable market dominance. Israel`s reliance on these top exporting nations underscores the importance of global partnerships in ensuring a consistent supply of gammaretroviral vectors for medical research and applications.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Gammaretroviral Vector Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Gammaretroviral Vector Market Revenues & Volume, 2022 & 2032F |
3.3 Israel Gammaretroviral Vector Market - Industry Life Cycle |
3.4 Israel Gammaretroviral Vector Market - Porter's Five Forces |
3.5 Israel Gammaretroviral Vector Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Israel Gammaretroviral Vector Market Revenues & Volume Share, By Disease Type, 2022 & 2032F |
3.7 Israel Gammaretroviral Vector Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.8 Israel Gammaretroviral Vector Market Revenues & Volume Share, By End-User, 2022 & 2032F |
4 Israel Gammaretroviral Vector Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Israel Gammaretroviral Vector Market Trends |
6 Israel Gammaretroviral Vector Market, By Types |
6.1 Israel Gammaretroviral Vector Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Gammaretroviral Vector Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Israel Gammaretroviral Vector Market Revenues & Volume, By Lentiviral Vectors, 2022 - 2032F |
6.1.4 Israel Gammaretroviral Vector Market Revenues & Volume, By Adenoviral Vectors, 2022 - 2032F |
6.1.5 Israel Gammaretroviral Vector Market Revenues & Volume, By Adeno-Associated Viral Vectors, 2022 - 2032F |
6.1.6 Israel Gammaretroviral Vector Market Revenues & Volume, By Other, 2022 - 2032F |
6.2 Israel Gammaretroviral Vector Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Gammaretroviral Vector Market Revenues & Volume, By Cancer, 2022 - 2032F |
6.2.3 Israel Gammaretroviral Vector Market Revenues & Volume, By Genetic Disorders, 2022 - 2032F |
6.2.4 Israel Gammaretroviral Vector Market Revenues & Volume, By Infectious Diseases, 2022 - 2032F |
6.2.5 Israel Gammaretroviral Vector Market Revenues & Volume, By Other, 2022 - 2032F |
6.3 Israel Gammaretroviral Vector Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Israel Gammaretroviral Vector Market Revenues & Volume, By Gene Therapy, 2022 - 2032F |
6.3.3 Israel Gammaretroviral Vector Market Revenues & Volume, By Vaccinology, 2022 - 2032F |
6.4 Israel Gammaretroviral Vector Market, By End-User |
6.4.1 Overview and Analysis |
6.4.2 Israel Gammaretroviral Vector Market Revenues & Volume, By Pharmaceutical and Biopharmaceutical, 2022 - 2032F |
6.4.3 Israel Gammaretroviral Vector Market Revenues & Volume, By Research Institutes, 2022 - 2032F |
7 Israel Gammaretroviral Vector Market Import-Export Trade Statistics |
7.1 Israel Gammaretroviral Vector Market Export to Major Countries |
7.2 Israel Gammaretroviral Vector Market Imports from Major Countries |
8 Israel Gammaretroviral Vector Market Key Performance Indicators |
9 Israel Gammaretroviral Vector Market - Opportunity Assessment |
9.1 Israel Gammaretroviral Vector Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Israel Gammaretroviral Vector Market Opportunity Assessment, By Disease Type, 2022 & 2032F |
9.3 Israel Gammaretroviral Vector Market Opportunity Assessment, By Application, 2022 & 2032F |
9.4 Israel Gammaretroviral Vector Market Opportunity Assessment, By End-User, 2022 & 2032F |
10 Israel Gammaretroviral Vector Market - Competitive Landscape |
10.1 Israel Gammaretroviral Vector Market Revenue Share, By Companies, 2025 |
10.2 Israel Gammaretroviral Vector Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here